Literature DB >> 32399588

Smart drug delivery against Helicobacter pylori: pectin-coated, mucoadhesive liposomes with antiadhesive activity and antibiotic cargo.

Maren Gottesmann1, Francisco M Goycoolea2, Tim Steinbacher3, Tamara Menogni4, Andreas Hensel5.   

Abstract

The first step in the development of Helicobacter pylori pathogenicity is the receptor-mediated adhesion to the gastric epithelium. Inhibition of outer membrane proteins of H. pylori (e.g. BabA) by antiadhesive drugs will contribute to reduced recolonization and infection. Pectin from apple inhibits the BabA and LPS-mediated adhesion of H. pylori to human stomach cells. Pectin-coated liposomes with encapsulated amoxicillin were characterized for polydispersity, zeta potential, encapsulation efficiency, stability, and amoxicillin release. Coated liposomes did not influence the viability of AGS and HT29-MTX cells up to 100 μg/mL but exert cytotoxicity against H. pylori at 10 μg/mL. Pectin-coating of liposomes provoked direct interaction and subsequent binding of the particles to surface structures of H. pylori, and interaction with mucus from porcine stomach and mucus secreted by HT29-MTX cells. Laser scanning microscopy of H. pylori and AGS cells together with liposomes indicated co-aggregation. The mucoadhesive effect seems interesting as stomach cells are covered by a mucus layer. H. pylori is able to penetrate and cross the mucin rapidly to reach pH-neutral epithelium to escape the acidic environment, followed by interaction with epithelial cells. In summary, all experimental evidence is consistent with a specific interaction of pectin-coated liposomes with mucins and surface structures of H. pylori. As the coated liposomes show mucoadhesion to the negatively charged mucins, docking to stomach mucin, mucus penetration, and recognition of and adhesion to H. pylori, they can be considered a novel type of multifunctional drug carriers for local antibiotic therapy against H. pylori. KEY POINTS: • Smart, multifunctional mucoadhesive liposomes • Specific targeting against BabA/LPS of Helicobacter pylori • Inhibition of bacterial adhesion of H. pylori to human host cells • Release of antibiotic cargo.

Entities:  

Keywords:  Adhesion; Bacterial antiadhesion; Helicobacter pylori; Liposomes; Mucoadhesion; Pectin

Mesh:

Substances:

Year:  2020        PMID: 32399588     DOI: 10.1007/s00253-020-10647-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  27 in total

1.  pH-dependent conformational change of gastric mucin leads to sol-gel transition.

Authors:  X Cao; R Bansil; K R Bhaskar; B S Turner; J T LaMont; N Niu; N H Afdhal
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

2.  BabA and LPS inhibitors against Helicobacter pylori: pectins and pectin-like rhamnogalacturonans as adhesion blockers.

Authors:  Maren Gottesmann; Vasiliki Paraskevopoulou; Aymen Mohammed; Franco H Falcone; Andreas Hensel
Journal:  Appl Microbiol Biotechnol       Date:  2019-11-25       Impact factor: 4.813

3.  Pre-formulation of liposomes against Helicobacter pylori: characterization and interaction with the bacteria.

Authors:  Pierre-Louis Bardonnet; Vincent Faivre; Paul Boullanger; Jean-Claude Piffaretti; Françoise Falson
Journal:  Eur J Pharm Biopharm       Date:  2008-01-31       Impact factor: 5.571

4.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

5.  Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chloride and potassium sorbate.

Authors:  J H Cho; Y S Kwun; H S Jang; J M Kang; Y S Won; H R Yoon
Journal:  Laryngoscope       Date:  2000-02       Impact factor: 3.325

Review 6.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

7.  A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength.

Authors:  E E Hassan; J M Gallo
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

8.  Occurrence of N-phenylpropenoyl-L-amino acid amides in different herbal drugs and their influence on human keratinocytes, on human liver cells and on adhesion of Helicobacter pylori to the human stomach.

Authors:  A Hensel; A M Deters; G Müller; T Stark; N Wittschier; T Hofmann
Journal:  Planta Med       Date:  2007-02-13       Impact factor: 3.352

9.  Phosphatidylcholine and cholesterol interactions in model membranes.

Authors:  W Guyer; K Bloch
Journal:  Chem Phys Lipids       Date:  1983-11       Impact factor: 3.329

10.  Structural basis of Lewis(b) antigen binding by the Helicobacter pylori adhesin BabA.

Authors:  Naim Hage; Tina Howard; Chris Phillips; Claire Brassington; Ross Overman; Judit Debreczeni; Paul Gellert; Snow Stolnik; G Sebastiaan Winkler; Franco H Falcone
Journal:  Sci Adv       Date:  2015-08-14       Impact factor: 14.136

View more
  6 in total

Review 1.  New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer.

Authors:  Xiang Zhu; Tingting Su; Shouhua Wang; Huiqing Zhou; Weibin Shi
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

Review 2.  Advances in Nanostructures for Antimicrobial Therapy.

Authors:  Josef Jampilek; Katarina Kralova
Journal:  Materials (Basel)       Date:  2022-03-24       Impact factor: 3.623

3.  Pelargonidin-3-O-Glucoside Encapsulated Pectin-Chitosan-Nanoliposomes Recovers Palmitic Acid-Induced Hepatocytes Injury.

Authors:  Naymul Karim; Mohammad Rezaul Islam Shishir; Yuting Li; Ould Yahia Zineb; Jianling Mo; Jitbanjong Tangpong; Wei Chen
Journal:  Antioxidants (Basel)       Date:  2022-03-24

Review 4.  Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations.

Authors:  Roberto Grosso; M-Violante de-Paz
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

Review 5.  Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives.

Authors:  Yongkang Lai; Wei Wei; Yiqi Du; Jie Gao; Zhaoshen Li
Journal:  Gut Microbes       Date:  2022 Jan-Dec

6.  Cosmetic-Derived Mannosylerythritol Lipid-B-Phospholipid Nanoliposome: An Acid-Stabilized Carrier for Efficient Gastromucosal Delivery of Amoxicillin for In Vivo Treatment of Helicobacter pylori.

Authors:  Yanping Wu; Jiayue Geng; Xiaohong Cheng; Ying Yang; Yu Yu; Lili Wang; Quanjiang Dong; Zhe Chi; Chenguang Liu
Journal:  ACS Omega       Date:  2022-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.